There was one dark side to the election results Tuesday night: Ohio. Issue 2 would have required state agencies to not pay more for prescription drugs than the federal Department of Veterans Affairs. Big Pharma put together a massive $60 million confuse-the-voters media campaign... that worked.
Big Pharma has spent tens of millions of dollars-- nearly $60 million as of last week-- on a contest in Ohio that hasn't gotten a lot of national attention. Issue 2 on today's ballot would have required state agencies to pay no more than what the U.S. Department of Veterans Affairs pays for prescription drugs. The drug companies were freaking out, not just because of Ohio but because Ohio would open a floodgate nationally of citizens who don't want to continue being ripped off by drug companies.
Since the begging of October, the Department of Health and Human Services (HHS) has been without an official secretary following the ouster of Tom Price, who resigned due to public outrage over his extensive and costly travel on private jets for government business and his personal use.
For me, one of the worst-- and longest lasting-- side effects from chemotherapy is peripheral neuropathy. I'll spare you the details but it's gotten worse, and continues to get worse, with time. Yesterday, my doctor told me that there are ongoing studies that show an anti-convulsive compound, lacosamide, which is used to treat epilepsy and seizures, has been effective for some people in treating peripheral neuropathy.
Democrats (!) who voted with Big Pharma and against prescription drug importation, along with "the amount they have taken from drug companies since being elected to federal office" (details here). How much longer should any of these "enemies of the people" be in office?
Wednesday, the Kaiser Family Foundation released a new study that goes a long way towards shedding light on what enactment of TrumpCare would actually mean to the millions of people with pre-existing conditions.
